Prospective Evaluation of a Modified Apnea Test in Brain Death Candidates that Does Not Require Disconnection from the Ventilator.
Apnea test
Apneic oxygenation
Brainstem areflexia
Irreversible loss of brain function
Ventilator-based
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
01 Jul 2024
01 Jul 2024
Historique:
received:
05
10
2023
accepted:
05
06
2024
medline:
2
7
2024
pubmed:
2
7
2024
entrez:
1
7
2024
Statut:
aheadofprint
Résumé
The apnea test (AT) is an important component in the determination of brain death/death by neurologic criteria (BD/DNC) and often entails disconnecting the patient from the ventilator followed by tracheal oxygen insufflation to ensure adequate oxygenation. To rate the test as positive, most international guidelines state that a lack of spontaneous breathing must be demonstrated when the arterial partial pressure of carbon dioxide (PaCO The mAT was performed in all 140 BD/DNC candidates registered between January 2019 and December 2022: after 10 min of preoxygenation, (1) positive end-expiratory pressure was increased by 2 mbar (1.5 mm Hg), (2) ventilation mode was switched to continuous positive airway pressure, and (3) apnea back-up mode was turned off (flow trigger 10 L/min). The mAT was considered positive when spontaneous breathing did not occur upon PaCO The mAT was possible in 139/140 patients and had a median duration of 15 min (interquartile range 13-19 min). Severe complications were not evident. In 51 patients, the post-mAT arterial partial pressure of oxygen (PaO The mAT is a safe and protective means of identifying patients who no longer have an intact central respiratory drive, which is a critical factor in the diagnosis of BD/DNC. Clinical trial registration DRKS, DRKS00017803, retrospectively registered 23.11.2020, https://drks.de/search/de/trial/DRKS00017803.
Sections du résumé
BACKGROUND
BACKGROUND
The apnea test (AT) is an important component in the determination of brain death/death by neurologic criteria (BD/DNC) and often entails disconnecting the patient from the ventilator followed by tracheal oxygen insufflation to ensure adequate oxygenation. To rate the test as positive, most international guidelines state that a lack of spontaneous breathing must be demonstrated when the arterial partial pressure of carbon dioxide (PaCO
METHODS
METHODS
The mAT was performed in all 140 BD/DNC candidates registered between January 2019 and December 2022: after 10 min of preoxygenation, (1) positive end-expiratory pressure was increased by 2 mbar (1.5 mm Hg), (2) ventilation mode was switched to continuous positive airway pressure, and (3) apnea back-up mode was turned off (flow trigger 10 L/min). The mAT was considered positive when spontaneous breathing did not occur upon PaCO
RESULTS
RESULTS
The mAT was possible in 139/140 patients and had a median duration of 15 min (interquartile range 13-19 min). Severe complications were not evident. In 51 patients, the post-mAT arterial partial pressure of oxygen (PaO
CONCLUSIONS
CONCLUSIONS
The mAT is a safe and protective means of identifying patients who no longer have an intact central respiratory drive, which is a critical factor in the diagnosis of BD/DNC. Clinical trial registration DRKS, DRKS00017803, retrospectively registered 23.11.2020, https://drks.de/search/de/trial/DRKS00017803.
Identifiants
pubmed: 38951444
doi: 10.1007/s12028-024-02035-w
pii: 10.1007/s12028-024-02035-w
doi:
Banques de données
DRKS
['DRKS00017803']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Kirschen MP, Lewis A, The GDM. American academy of neurology, american academy of pediatrics, child neurology society, and society of critical care medicine pediatric and adult brain death/death by neurologic criteria determination consensus guidelines: what the critical care team needs to know. Crit Care Med. 2023. https://doi.org/10.1097/CCM.0000000000006099 .
doi: 10.1097/CCM.0000000000006099
pubmed: 37921516
pmcid: 11036878
Montgomery FU, Scriba PC, Tonn J-C and Angstwurm H. Richtlinie gemäß § 16 Abs. 1 S. 1 Nr. 1 TPG für die Regeln zur Feststellung des Todes nach § 3 Abs. 1 S. 1 Nr. 2 TPG und die Verfahrensregeln zur Feststellung des endgültigen, nicht behebbaren Ausfalls der Gesamtfunktion des Großhirns, des Kleinhirns und des Hirnstamms nach § 3 Abs. 2 Nr. 2 TPG, Vierte Fortschreibung. (Vierte Fortschreibung).
Silvester W, Bevan R, Brieva J, Cook D, D’Costa R, Dobb G, Gelbart B, Jones S, Judson J, Modra L, Moodie S, Opdam H, Poynter C, Streat S. The Statement on Death and Organ Donation. Edition 4.1. Australian and New Zealand Intensive Care Society (ANZICS); 2021.
Simpson P, Bates D, Bonner S, Costeloe K, Doyal L, Falvey S, Gaffin J, Howard R, Kane N, Kennedy CR, Kennedy I, Kerr S, Manara A, Pickard J, Rolles K, Short A. A code of practice for the diagnosis and confirmation of death. Academy of Medical Royal Colleges; 2008.
Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, et al. Determination of brain death/death by neurologic criteria: the world brain death project. JAMA. 2020;324(11):1078–97. https://doi.org/10.1001/jama.2020.11586 .
doi: 10.1001/jama.2020.11586
pubmed: 32761206
Wijdicks EFM, Varelas PN, Gronseth GS, Greer DM. American Academy of Neurology: Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911–8.
doi: 10.1212/WNL.0b013e3181e242a8
pubmed: 20530327
Schwarz G, Errath M, Arguelles Delgado P, Schöpfer A, Cavic T. Ventilator autotriggering : an underestimated phenomenon in the determination of brain death. Anaesthesist. 2019;68(3):171–6.
doi: 10.1007/s00101-019-0555-5
pubmed: 30810759
Yee AH, Mandrekar J, Rabinstein AA, Wijdicks EF. Predictors of apnea test failure during brain death determination. Neurocrit Care. 2010;12(3):352–5.
doi: 10.1007/s12028-010-9343-4
pubmed: 20217276
Hocker S, Whalen F, Wijdicks EFM. Apnea testing for brain death in severe acute respiratory distress syndrome: a possible solution. Neurocrit Care. 2014;20(2):298–300.
doi: 10.1007/s12028-013-9932-0
pubmed: 24233817
Mascia L, Sakr Y, Pasero D, Payen D, Reinhart K, Vincent JL, et al. Extracranial complications in patients with acute brain injury: a post-hoc analysis of the SOAP study. Intensive Care Med. 2008;34(4):720–7. https://doi.org/10.1007/s00134-007-0974-7 .
doi: 10.1007/s00134-007-0974-7
pubmed: 18175107
Goudreau JL, Wijdicks EF, Emery SF. Complications during apnea testing in the determination of brain death: predisposing factors. Neurology. 2000;55(7):1045–8.
doi: 10.1212/WNL.55.7.1045
pubmed: 11061269
Migdady I, Shoskes A, Amin M, Cho SM, Rae-Grant A, George P. Determination of brain death in patients undergoing short-term mechanical circulatory support devices. Heart Lung Circ. 2022;31(2):239–45.
doi: 10.1016/j.hlc.2021.05.100
pubmed: 34210616
Giani M, Scaravilli V, Colombo SM, Confalonieri A, Leo R, Maggioni E, et al. Apnea test during brain death assessment in mechanically ventilated and ECMO patients. Intensive Care Med. 2016;42(1):72–81. https://doi.org/10.1007/s00134-015-4105-6 .
doi: 10.1007/s00134-015-4105-6
pubmed: 26556611
Lévesque S, Lessard MR, Nicole PC, Langevin S, LeBlanc F, Lauzier F, et al. Efficacy of a T-piece system and a continuous positive airway pressure system for apnea testing in the diagnosis of brain death. Crit Care Med. 2006;34(8):2213–6.
doi: 10.1097/01.CCM.0000215114.46127.DA
pubmed: 16540953
Kramer AH, Couillard P, Bader R, Dhillon P, Kutsogiannis DJ, Doig CJ. Prevention of hypoxemia during apnea testing: a comparison of oxygen insufflation and continuous positive airway pressure. Neurocrit Care. 2017;27(1):60–7.
doi: 10.1007/s12028-017-0380-0
pubmed: 28176180
Lang CJG, Heckmann JG. Apnea testing for the diagnosis of brain death. Acta Neurol Scand. 2005;112(6):358–69.
doi: 10.1111/j.1600-0404.2005.00527.x
pubmed: 16281917
Gutmann DH, Marino PL. An alternative apnea test for the evaluation of brain death. Ann Neurol. 1991;30(6):852–3. https://doi.org/10.1002/ana.410300620 .
doi: 10.1002/ana.410300620
pubmed: 1789700
Benzel EC, Mashburn JP, Conrad S, Modling D. Apnea testing for the determination of brain death: a modified protocol. Technical note J Neurosurg. 1992;76(6):1029–31.
pubmed: 1588410
Solek-Pastuszka J, Sawicki M, Iwańczuk W, Bohatyrewicz R. Ventilator-delivered continuous positive airway pressure for apnea test in the diagnosis of brain death in patient with extremely poor baseline lung function—case report. Transplant Proc. 2016;48(7):2471–2.
doi: 10.1016/j.transproceed.2016.02.089
pubmed: 27742325
Ahlawat A, Carandang R, Heard SO, Muehlschlegel S. The modified apnea test during brain death determination: an alternative in patients with hypoxia. J Intensive Care Med. 2016;31(1):66–9.
doi: 10.1177/0885066615599086
pubmed: 26574562
Winter S, Groesdonk HV, Beiderlinden M. Apnea test for assessment of brain death under extracorporeal life support. Med Klin Intensivmed Notfallmedizin. 2019;114(1):15–20.
Horovitz JH, Carrico CJ, Shires GT. Pulmonary Response to Major Injury. Arch Surg. 1974;108(3):349–55. https://doi.org/10.1001/archsurg.1974.01350270079014 .
doi: 10.1001/archsurg.1974.01350270079014
pubmed: 4813333
Wijdicks EFM, Rabinstein AA, Manno EM, Atkinson JD. Pronouncing brain death: contemporary practice and safety of the apnea test. Neurology. 2008;71(16):1240–4.
doi: 10.1212/01.wnl.0000327612.69106.4c
pubmed: 18852438
Datar S, Fugate J, Rabinstein A, Couillard P, Wijdicks EFM. Completing the apnea test: decline in complications. Neurocrit Care. 2014;21(3):392–6.
doi: 10.1007/s12028-014-9958-y
pubmed: 24522760
Wijdicks EFM. Biot’s breathing. J Neurol Neurosurg Psychiatry. 2007;78(5):512–3.
doi: 10.1136/jnnp.2006.104919
pubmed: 17435185
pmcid: 2117832
Summ O, Hassanpour N, Mathys C, Groß M. Disordered breathing in severe cerebral illness: towards a conceptual framework. Respir Physiol Neurobiol. 2022;300: 103869.
doi: 10.1016/j.resp.2022.103869
pubmed: 35181538
Whited L, Hashmi MF, Graham DD. Abnormal Respirations. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Nov 28]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470309/
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33.
Lang CJG. Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation. Intensive Care Med. 1997;23(8):903–7. https://doi.org/10.1007/s001340050430 .
doi: 10.1007/s001340050430
pubmed: 9310811
Scott JB, Gentile MA, Bennett SN, Couture M, MacIntyre NR. Apnea testing during brain death assessment: a review of clinical practice and published literature. Respir Care. 2013;58(3):532–8.
doi: 10.4187/respcare.01962
pubmed: 22709413
Crystal GJ. Carbon dioxide and the heart: physiology and clinical implications. Anesth Analg. 2015;121(3):610.
doi: 10.1213/ANE.0000000000000820
pubmed: 26287294
Schotola H, Toischer K, Popov AF, Renner A, Schmitto JD, Gummert J, et al. Mild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardium. Crit Care. 2012;16(4):R153.
doi: 10.1186/cc11468
pubmed: 22889236
pmcid: 3580742